WHO says stop giving benzodiazepines after trauma

WHO releases guidance on mental health care after trauma
New clinical protocol and guidelines to enable effective mental health care for adults and children exposed to trauma and loss
News release
6 AUGUST 2013


GENEVA - WHO is releasing new clinical protocols and guidelines to health-care workers for treating the mental health consequences of trauma and loss.

Mental disorders are common, disabling and usually untreated, and WHO’s "Mental Health Global Action Programme (mhGAP)" was developed in 2008 to scale-up care for mental, neurological and substance use disorders with simple treatment protocols that can be offered by primary health-care doctors and nurses.

New care protocols for post-traumatic stress disorder and others

Now, WHO is extending this programme by including care for post-traumatic stress disorder (PTSD), acute stress and bereavement within its global programme.

“We have received numerous requests for guidance for mental health care after trauma and loss” says Dr Oleg Chestnov, WHO Assistant Director-General for Noncommunicable Diseases and Mental Health. “Primary health-care providers will now be able to offer basic support consistent with the best available evidence. They will also learn when to refer to more advanced treatment.”

Warnings against some popular treatments

Primary health care staff are also warned against certain popular treatments. For example, benzodiazepines, which are anti-anxiety drugs, should not be offered to reduce acute traumatic stress symptoms or sleep problems in the first month after a potentially traumatic event.

“PTSD needs to be managed along with other common mental disorders” reports Dr Mark van Ommeren, Scientist in the WHO Department of Mental Health and Substance Abuse. “This new, simple WHO-UNHCR treatment protocol will guide health workers around the world to help adults and children who suffer from conditions specifically related to stress.” The new guidelines and protocol were published today in an article in "The Journal of the American Medical Association".

read more here

BENZODIAZEPINES
Ativan
Dalmane
Doral
Estazolam
Flurazepam
Halcion
Lorazepam
Midazolam HCL
Prosom
Restoril
Temazepam
Triazolam
Alprazolam
Ativan
Chlordiazepoxide
Clorazepate
Diazepam
Librium
Lorazepam
Oxazepam
Serax
Tranxene SD
Tranxene T
Valium
Xanax
Xanax XR
Clonazepam
Klonopin